ArticleNature microbiology2021
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
Open access · bronzeAbstract read
In one paragraph
Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.
0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
2.9field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 155 citations in OpenAlex.
- Immunological Mechanisms and Machine Learning Applications in Post-COVID-19 Syndrome: A Narrative Review.Microorganisms · 2026Article
- Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4.Journal of virology · 2026Article
- Systematic profiling of SARS-CoV-2 structural protein-specific T cell epitopes in Omicron infections following inactivated vaccination.iScience · 2026Article
- Severity-associated cross-reactive anti-sarbecovirus antibody responses in COVID-19 convalescents and isolation of a dual-targeting monoclonal antibody with cross-neutralizing activity.Frontiers in immunology · 2026Article
- Sequence-only prediction of binding affinity changes: a robust and interpretable model for antibody engineering.Bioinformatics (Oxford, England) · 2025Article
- Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy.International journal of molecular sciences · 2025Review
- The GP2a 91/97/98 amino acid substitutions play critical roles in determining PRRSV tropism and infectivity but do not affect immune responses.Journal of virology · 2025Article
- Activation of CXCR3Journal of virology · 2025Article
- A tentative exploration for the association between influenza virus infection and SARS-CoV-2 infection in Shihezi, China: A test-negative study.Infectious Disease Modelling · 2025Article
- Immune responses in pulmonary sarcoidosis following COVID-19.Frontiers in immunology · 2025Article
- Broad cross neutralizing antibodies against sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans.NPJ vaccines · 2024Article
- COVID-19: from immune response to clinical intervention.Precision clinical medicine · 2024Review
- Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease.Journal of lipid and atherosclerosis · 2024Review
- Atypical and non-classical CD45RBNature communications · 2024Article
- Correlation between circulating T follicular helper cell levels after infection and a decreased risk of COVID-19 re-infection.Virologica Sinica · 2024Article
- Article
- Neutralizing immunity against coronaviruses in Tanzanian health care workers.Scientific reports · 2024Article
- A chimeric porcine reproductive and respiratory syndrome virus 1 strain containing synthetic ORF2-6 genes can trigger T follicular helper cell and heterologous neutralizing antibody responses and confer enhanced cross-protection.Veterinary research · 2024Article
- The immune response to SARS-CoV-2 in people with HIV.Cellular & molecular immunology · 2024Review
- Destabilisation of T cell-dependent humoral immunity in sepsis.Clinical science (London, England : 1979) · 2024Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 6 institutions in 1 country.
Jian Zhang *Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.ORCID http://orcid.org/0000-0002-5982-419X
Qian Wu *Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Ziyan Liu *Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Qijie Wang *The Central Hospital of Shaoyang, Shaoyang, China.
Jiajing Wu *National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Key Laboratory of Biological Product Quality Research and Evaluation of National Medical Products Administration, Beijing, China.
Yabin Hu *Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Tingting BaiThe First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Ting XieThe Central Hospital of Shaoyang, Shaoyang, China.
Mincheng HuangThe Central Hospital of Shaoyang, Shaoyang, China.
Tiantian WuInstitute of Human Virology, Zhongshan School of Medicine, and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou, China.
Danhong PengThe Central Hospital of Shaoyang, Shaoyang, China.
Weijin HuangNational Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Key Laboratory of Biological Product Quality Research and Evaluation of National Medical Products Administration, Beijing, China.ORCID http://orcid.org/0000-0002-4246-8889
Kun JinTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Ling NiuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Wangyuan GuoTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Dixian LuoTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Dongzhu LeiTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Zhijian WuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Guicheng LiTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Renbin HuangTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Yingbiao LinTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China.
Xiangping XieThe Central Hospital of Shaoyang, Shaoyang, China.
Shuangyan HeThe Central Hospital of Shaoyang, Shaoyang, China.
Yunfan DengThe Longhui People's Hospital, Longhui, China.
Jianghua LiuThe Xinshao People's Hospital, Xinshao, China.
Weilang LiThe Dongkou People's Hospital, Dongkou, China.
Zhongyi LuThe Shaoyang People's Hospital, Shaoyang, China.
Haifu ChenThe Suining People's Hospital, Suining, China.
Ting ZengThe Central Hospital of Shaoyang, Shaoyang, China.
Qingting LuoThe Baoqing Psychiatric Hospital, Shaoyang, China.
Yi-Ping LiInstitute of Human Virology, Zhongshan School of Medicine, and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou, China. lyiping@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0001-6011-3101
Youchun WangNational Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Key Laboratory of Biological Product Quality Research and Evaluation of National Medical Products Administration, Beijing, China. wangyc@nifdc.org.cn.ORCID http://orcid.org/0000-0001-9769-5141
Wenpei LiuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China. wenpeiliu_2008@foxmail.com.ORCID http://orcid.org/0000-0002-4624-2879
Xiaowang QuTranslational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, China. quxiaowang@163.com.ORCID http://orcid.org/0000-0002-8135-7292
Chenzhou First People's Hospital · CNThe Central Hospital of Shaoyang · CNNational Medical Products Administration · CNSun Yat-sen University · CNSouthern Medical University · CNWenzhou Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Indexed as
Antibodies, NeutralizingAntibodies, ViralBroadly Neutralizing AntibodiesCOVID-19Cross ReactionsHumansReceptors, CXCR3SARS-CoV-2T Follicular Helper CellsAntibodies, NeutralizingAntibodies, ViralBroadly Neutralizing AntibodiesCXCR3 protein, humanReceptors, CXCR3
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.